Company / Current Assets per Share
Ovid Therapeutics Inc. Current Assets per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$1.05
FY2025
5-year range
$0.79 / $1.87
FY2022-FY2025
Trend
+32.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share returned to growth in FY2025 after 2 years of decline, reaching $1.05.
Based on SEC 10-K filings.
1.05 in FY2025 with a 3-year CAGR of -17.5%.
Declined from $1.56 to $1.05 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -17.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current assets per share increased 32.3% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.61 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.05 | +32.3% |
| FY2024 | $0.79 | -49.1% |
| FY2023 | $1.56 | -16.7% |
| FY2022 | $1.87 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026